Physician Assistant in Darlington, SC Accepting Medicare

3 Physician Assistant nurses found. Showing 1 - 3

Mr. Isaac B Snapp, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 201 Cashua St, Darlington, SC 29532 Phone: 843-393-7452    Fax: 843-393-6210

Laurel Dennis, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1532 Woodspond Dr, Darlington, SC 29540 Phone: 843-676-5680

Mr. Usman Amash Tohid, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 701 Cashua Ferry Rd, Darlington, SC 29532 Phone: 843-777-4200    Fax: 843-777-4296

News Archive

Palin resurrects 'death panel' claims, controversy is decades-old

Sarah Palin has returned to the battle over health care reform with a familiar refrain, slamming what she and others dubbed 'death panels' over the summer. Following passage of the health care overhaul in the House on Saturday night, Palin took to her Facebook page to register her well-known opposition to the Democratic plan.

FDA Arthritis Advisory Committee recommends approval of BENLYSTA for SLE

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 2 to recommend that the FDA approve BENLYSTA (belimumab) for the treatment of autoantibody-positive patients with active systemic lupus erythematosus (SLE).

New gene testing method can identify mutations, prioritize variants in breast and ovarian cancer genes

A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.

Angiochem reports Phase 1/2 efficacy study results of ANG1005 for treating brain cancer

Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.

Read more Medical News

› Verified 2 days ago